Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril and Coreg CR for Cardiotoxicity Prevention in Breast Cancer
NCT01009918Phase 2Completed
- Sponsor
- University of South Florida
- Start
- Mar 2010
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisinopril, carvedilol in cardiac toxicity, sponsored by University of South Florida. Started Mar 2010; status: completed.
02
Drugs
lisinoprilcarvedilol
03
Conditions
cardiac toxicity
Beyond the preview
Go deeper on NCT01009918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009918.